Adrian Z. Stecyk

Headquartered in New York City, Griffin Securities, Inc. is a research-driven investment banking firm providing corporate finance, merger & acquisitions, brokerage and investment opportunities for institutional, corporate and private clients. Orders can be entered on major U.S. exchanges and most international exchanges. Positions can be held in multiple currencies. Griffin's research focuses on delivering objective, value-added research and winning ideas in several industries including healthcare/biotechnology, technology and telecommunications. They are a member of the NASD and the SIPC. Griffin Securities was founded in 1997.

Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA.

Griffin Group Plc provides financial and brokerage services. It provides clients with on-line and broker assisted open market transactions and has also added a niche service in processing and placing securities

Dialog Group, Inc. provides advertising and marketing services. It engages in the provision of broad spectrum of proprietary and exclusive databases for healthcare, consumer and business-to-business market clients. The company was founded in 1982 and is headquartered in New York, NY.